DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 3004--------------------------------------------------
       (Abst.) Adverse event profile differences between Rituxan and Oc
       revus...
       By: agate Date: August 25, 2020, 1:21 am
       ---------------------------------------------------------
       From Multiple Sclerosis Journal (August 24, 2020), "Adverse
       event profile differences between rituximab and ocrelizumab:
       Findings from the FDA Adverse Event Reporting Database":
  HTML https://journals.sagepub.com/doi/abs/10.1177/1352458520949986
       #Post#: 3006--------------------------------------------------
       (MS News Today) MS infection risk for Ocrevus higher than Rituxa
       n but cancer risk lower
       By: agate Date: August 26, 2020, 11:25 pm
       ---------------------------------------------------------
       More on this in Multiple Sclerosis News Today (August 26,
       2020)--"MS infection risk for Ocrevus higher than Rituximab but
       cancer risk lower":
  HTML https://bit.ly/2YDIxmm
       *****************************************************